
Tazab 4000mg/500mg Injection
Marketer
Triple A Pharma
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazab 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, dosage and frequency are determined by a physician based on individual health needs. Strict adherence to prescribed usage is crucial. Potential side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical consultation. Prior to use, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; dosage adjustments or alternative treatments may be necessary. While generally safe during pregnancy and lactation under medical guidance, physician oversight is essential.
Uses of Tazab 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazab 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Tazab 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazab 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Tazab 4000mg/500mg Injection works:
Tazab 4000mg/500mg injection combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tazab 4000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazab, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication, Tazab 4000mg/500mg, presents a low risk during lactation. Research in humans indicates minimal transfer of the drug into breast milk, posing no appreciable threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazab 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use the 4000mg/500mg Tazab Injection cautiously. Dosage modification of the 4000mg/500mg Tazab Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazab 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Tazab 4000mg/500mg Injection :
Should you forget a scheduled dose of Tazab 4000mg/500mg Injection, seek advice from your physician.
Facts to Know About Tazab 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
